The group arrived at another laboratory, where several White Mouse were kept in cages in the corner.
At Wei Kang's suggestion, the researchers began to explain in detail.
"These five mice were injected with a new painkiller five minutes ago, and it should be working now. The mice should have temporarily lost their sense of pain. Let's verify how effective the drug is."
The researcher took out a mouse and, in full view of everyone, swiftly cut off a section of its tail.
The expected squeaks and screams did not come. The mouse remained unmoved and showed no reaction whatsoever, as if its tail had not been cut off, but only a few hairs had been lost.
Du Cheng opened his eyes wide and carefully observed the mouse, marveling at it.
The tailless mouse was simply bandaged and put back in its cage. Surprisingly, it walked to its food bowl as if nothing had happened and began to eat with relish.
The visitors were all amazed by what they saw, and then the researchers handed over several Phase III clinical trial reports.
"This painkiller has reached Phase III. If all goes well, it will be approved and launched on the market soon."
"This is a novel non-opioid analgesic that blocks certain ion channels in neurons that are involved in transmitting pain stimuli. It has a high safety profile, strong analgesic effect, no sedative effect, and no addictive properties."
Du Cheng's eyes lit up, and he reached out to take the Phase III clinical trial report, which he then carefully read.
The others also showed interest and were carefully reading the report.
Painkillers are a very old and large market, originating from ancient opioids and drugs such as Morphine extracted from them, which are still widely used in people's lives today.
As the global population ages, more and more people will be affected by chronic pain. In addition, the increase in surgical and oral surgeries in recent years has also driven the demand for painkillers, and people's need for pain relief is growing day by day.
The global painkiller market is worth $71 billion and is projected to grow to $92 billion over the next five years.
Currently, Opioid Painkiller and nonsteroidal anti-inflammatory drugs (NSAIDs) dominate the analgesic market, with Opioid Painkiller being the dominant type in overseas markets, while the latter leads in other regions.
China's painkiller market is relatively small, currently valued at approximately $530 million, with the majority of its products used for surgical pain relief. This lags significantly behind developed countries. However, with an aging population and rapidly increasing incidence of diseases such as Cancer, chronic painkillers, primarily opioids, are gradually taking over the domestic pharmaceutical market.
Pain can be divided into acute pain and chronic pain. Acute pain includes trauma and postoperative pain, while chronic pain involves a variety of diseases, including neuropathic pain (neuralgia, migraine, Diabetes neuropathy, etc.); sensory nociceptive pain (Osteoporosis and Rheumatoid Arthritis); organ-related pain (visceral pain, Pancreatitis, etc.); mixed pain (lower back pain, cancer pain, fibromyalgia, etc.), and so on.
Statistics show that the global prevalence of pain is about 20%, half of which comes from chronic pain.
Opioids primarily work by inhibiting the pain center in the brain, and have a strong analgesic effect. They are commonly used for acute and postoperative pain, Cancer- related pain, and moderate to severe chronic pain.
Opioids do not have Smallpox effect; their analgesic effect can be increased by raising the dosage. However, long-term use can lead to addiction. Common examples include Morphine, oxycodone, Fentanyl, and Tramadol.
Drug addiction caused by the overuse of such painkillers has long been a very thorny social problem in overseas countries.
Nonsteroidal anti-inflammatory drugs (NSAIDs) achieve their analgesic effect by inhibiting the synthesis of pain-causing substances associated with inflammation. They are suitable for pain caused by inflammation and postoperative pain.
These types of painkillers are not addictive, but their analgesic effect is relatively weak and they have Smallpox effect. This means that once a certain dosage is reached, increasing the dosage will not enhance the analgesic effect, but will only increase various side effects, including gastrointestinal bleeding, Myocardial Infarction, and stroke. Commonly used Aspirin and Ibuprofen belong to this category.
As the problem of opioid abuse has become increasingly serious, various opioid manufacturers have withdrawn their products and stopped promotions, leading to the gradual decline of opioids.
However, the analgesic effect of nonsteroidal anti-inflammatory drugs is too weak to be satisfactory.
Therefore, major pharmaceutical companies have turned their attention to the research and development of other types of painkillers, eagerly hoping to discover a new and potent painkiller.
However, non-addictive, non-sedative, potent painkillers remain a dream. Even now, the most effective painkillers are still opium preparations that have existed since the Stone Age.
Opium preparations are not only the world's best-selling painkillers, but also the best-selling drugs of all, with hundreds of millions of prescriptions issued each year to relieve people's severe pain.
However, with the development of science and technology, in the past 20 years, major pharmaceutical companies have been inspired by patients with congenital analgesia and discovered a channel that controls the entry of sodium ions into sensory neurons. People who have lost the function of this channel are congenitally insensitive to pain stimuli, which quickly made the neuronal analgesia pathway a potential analgesic target.
Three Purities, a pain reliever, is a new type of drug that can act on the pain pathway. It can suppress pain of any degree, which is equivalent to temporarily cutting off the pain transmission between neural networks, so that people cannot feel pain.
After taking it, people can perfectly experience the feeling of congenital insensitivity to pain.
The absence of pain sounds wonderful, but in reality, it's a terrifying thing in daily life.
Pain can help people avoid injury, such as putting their hand into boiling water or hitting their leg with their head.
In developing countries, people who cannot feel pain often die young. In developed countries, they are able to live to adulthood if their families have sufficient resources to monitor them 24/7 and ensure they are not injured.
Fortunately, painkillers only temporarily relieve people of pain, which is a dream come true for patients who have been suffering from illness for a long time.
Pain is one of the most common forms of suffering for humans, and it is a symptom that everyone experiences.
The new pain reliever Three Purities offers a more reliable and safer treatment option than other pain relievers, which will be a boon for everyone.
"Fantastic! These clinical trial data are simply amazing." Du Cheng couldn't help but slap the table in admiration.
"Three Purities has shown remarkable performance in treating more than ten types of pain, including neurogenic migraine, rheumatoid arthritis pain, and chronic Cancer pain. It can greatly reduce the pain of patients, and is well tolerated with no obvious adverse reactions."
"This is exactly what our soldiers need. In battlefield medical care, not only is stopping bleeding important, but pain relief is also an essential part."
Du Cheng closed the test report and said to Wei Kang with an excited look on his face, "I believe that hemostatic spray and painkillers can not only become special medicines for the army, but also become important strategic materials."
"President Wei, please register the military drug approval number for the painkiller as soon as possible and submit the clinical data. We will expedite the approval process. We can discuss the specific requirements again this afternoon."
Wei Kang smiled and nodded. This result was within his expectations. Three Purities had produced two special military medicines at once, which was a positive development from any perspective.
I just don't know what this so-called strategic material means, and what specific impact it will have.
After all, painkillers are a gold molecule worth tens of billions of US dollars.